Q-omics provides the consensus-scored BDP1P profile across patient tissues and cancer cell-line models. BDP1P expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in PAAD. Among the 18 cancer types available for tumor–normal comparison, BDP1P is differentially expressed in 4, with the highest sampling consensus in COAD. Additionally, BDP1P RNA expression shows 7,180 significant protein co-abundance associations, with the highest sampling consensus in GBM. Together, these results highlight PAAD, COAD, and GBM as cancer lineages where BDP1P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for BDP1P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes BDP1P survival associations across molecular data types. BDP1P RNA expression shows survival associations in the most cancer types (16). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible BDP1P RNA expression–survival associations across cancer types. High BDP1P expression shows unfavorable associations in PAAD, THCA, KIRC and CHOL, but favorable associations in BRCA and LUSC. The PAAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify PAAD as the clearest survival context for BDP1P RNA expression.
This table summarizes BDP1P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in COAD for RNA.
This table ranks reproducible tumor–normal expression differences for BDP1P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. BDP1P shows lower tumor expression in ESCA and higher tumor expression in COAD, KICH and HNSC. The COAD box plot shows higher BDP1P RNA expression in tumor versus normal tissue (log2 FC = +0.020, t-test p = .042).
This table shows molecular features associated with BDP1P in patient tissues and cancer cell lines. In patient samples, BDP1P shows the broadest associations at the RNA and protein expression levels, with GBM recurring as the lineage with the largest associated feature set.
